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Primary tracheal malignant lymphoma is a rare disease; only 30 cases have been reported to date.  A 
73-year-old Japanese man with a history of asbestos exposure was undergoing biannual chest com-
puted tomography (CT) twice a year as a routine procedure for those previously exposed to asbestos.  
He had been smoking since the age of 32.  In September 2010,  chest CT during this regular checkup 
revealed a polypoid lesion in his trachea and pleural plaques,  which were suspected to be caused by 
asbestos.  Bronchoscopy performed in October revealed a polypoid lesion with granules and nodules in 
the trachea.  A diagnosis of non-Hodgkin lymphoma (NHL) and extranodal marginal-zone B-cell lym-
phoma of mucosa-associated lymphoid tissue (MALT) was conﬁrmed by histological analysis of the 
biopsy specimens.  To our knowledge,  this is the ﬁrst case of primary tracheal lymphoma associated 
with a history of asbestos exposure.  Several reports have documented no correlation between asbestos 
and malignant lymphoma.  In addition,  the correlation between smoking and NHL is weak.  Although 
we cannot exclude the possibility of a simple coincidence of asbestos,  smoking,  and tracheal lym-
phoma,  this case suggests that asbestos and smoking might have multiplicative eﬀects in the develop-
ment or progression of tracheal lymphoma.
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rimary tracheal tumor is a rare disease com-
prising only 0.1ｵ of all malignancies with the 
most frequently representing types being squamous 
cell carcinoma and adenoid cystic carcinoma [1].  Non-
Hodgkin lymphoma (NHL) conﬁned to the trachea is 
exceedingly rare and is estimated to account for less 
than 0.5ｵ of all tracheal tumors.  To date,  fewer 
than 30 cases of primary tracheal NHL have been 
reported in the literature [2].
　 We report a tracheal lymphoma detected in a 
73-year-old man with a history of exposure to asbes-
tos dust and smoking,  who had been undergoing bian-
nual chest CT as a part of his routine checkup.
Case Report
　 A 73-year-old man had been undergoing biannual 
chest CT since March 2010 as part of his routine 
checkups as he had worked in the construction indus-
try and had been exposed to asbestos dust for three 
years.  In addition,  he had a history of hypertension 
and diabetes mellitus,  for which he had been referred 
to another hospital.  His father,  older brother,  and 
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younger sister had died due to hepatocellular carci-
noma.  He had smoked about half a pack of cigarettes 
daily since the age of 32.
　 In September 2010,  chest CT performed during a 
regular checkup revealed a polypoid lesion in his tra-
chea (Fig.  1A,  1B).  Pleural plaques were observed 
as well (Fig.  1C).  In October,  bronchoscopy revealed 
a polypoid lesion with granules and nodules.  Capillaries 
were observed on the surface of the lesion,  and except 
for the area of the lesion,  the trachea appeared to be 
normal (Fig.  2).  During biopsy,  the lesion was soft.  
Histological analysis of the biopsy specimen revealed 
small-to-medium-sized lymphocytes inﬁltrating the 
subepithelial connective tissue (Fig.  3A).  The lym-
phoma cells resembled centrocytes,  which have 
slightly irregular nuclei with moderately dispersed 
chromatin and inconspicuous nucleoli.  Plasma cell 
diﬀerentiation with Dutcher bodies was present (Fig.  
3B).  Immunophenotypically,  tumor cells were positive 
for B-cell marker CD20,  and negative for CD3,  CD5,  
CD10 and the cyclin D1,  in addition Ig-Kppa mono-
typic and Ki-67 labeling indexes were low.  A histo-
logical diagnosis of extranodal marginal zone lym-
phoma of mucosa-associated lymphoid tissue (MALT 
lymphoma) was conﬁrmed.  The lesion was insigniﬁ-
cant and was quite diﬃcult to detect in a chest CT 
recorded half a year back in March,  2010; however,  
it was observed to be enlarged on the chest CT 
recorded in September,  2010.  Treatment was deemed 
necessary because of disease progression.
　 The patient was admitted to our hospital on 
January 18,  2011.  His serum was negative for HBs 
antigen,  and HBV-DNA could not be detected in his 
serum by PCR.  Cervical,  chest,  abdominal,  and 
pelvic CT did not indicate any involvement of lymph 
nodes or visceral organs.  The Ann Arbor stage of the 
lesion was determined to be IE.  From the 8th day,  he 
was administered 500mg rituximab intravenously four 
times in a month with a one-week interval; no adverse 
eﬀects related to rituximab administration were 
observed.  He was discharged on February 10,  2011.  
Thereafter,  in March 2011,  chest CT and bronchos-
copy revealed tumor regression.  He has been followed 
up with a biannual chest CT in our hospital without 
further treatment since then; he has been healthy 
through his last follow-up,  conducted in March 2013.
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Fig. 1　 A and B,  Non-enhanced transverse CT images during a 
regular checkup in September 2010 obtained at the level of the 
brachiocephalic trunk showing multiple,  smooth surface,  small 
nodular polypoid lesions along the right inner wall of trachea; C,  
Right pleural thickening with calciﬁed plaques above the diaphragm 
were seen.
Discussion
　 In this case,  our ﬁndings suggest that polypoid 
lesions on the trachea should not be overlooked in 
chest CT,  even though the trachea has a smaller 
proportion of abnormalities compared with that in the 
lung or mediastinum.
　 The non-Hodgkin lymphoma subtype of marginal 
zone lymphoma includes 3 distinct diseases that have 
been historically classiﬁed together because they 
appear to arise from post-germinal-center marginal-
zone B cells and share a similar immunophenotype:  
positive for B-cell markers CD19,  CD20,  and CD22,  
and negative for CD5,  CD10,  and usually CD23.  The 
three diseases in this category that are recognized in 
the REAL/WHO classiﬁcation systems include extra-
nodal marginal-zone B-cell lymphoma of mucosa-asso-
ciated lymphoid tissue (MALT) type (MALT-type 
lymphoma,  MALT lymphoma),  nodal marginal-zone 
B-cell lymphoma,  and splenic marginal-zone B-cell 
lymphoma (± villous lymphocytes) [3].  Extranodal 
marginal-zone B-cell lymphoma,  also called MALT,  is 
an extranodal lymphoma that arises in a number of 
epithelial tissues,  including the stomach,  salivary 
gland,  lung,  small bowel,  and thyroid.  Extranodal 
MZL constitutes about 5ｵ of all NHLs [3],  and 
almost 50ｵ of all gastric lymphomas [4-6].  A sub-
group of extranodal MZL,  bronchus-associated lym-
phoid tissue (BALT) lymphoma,  comprises 1ｵ of all 
lymphomas and more than two-thirds of all primary 
NHLs of the lung [7].
　 With regard to Ann Arbor stage-IE NHL conﬁned 
to the trachea,  chemotherapy,  radiotherapy,  or surgi-
cal resection has been recommended for management 
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Fig. 2　 Bronchoscopy revealed a polypoid lesion with granules 
and nodules.
Ａ Ｂ
Fig. 3　 Histological analysis of the biopsy specimen.  A,  Low-power magniﬁcation of Hematoxylin and Eosin staining showing inﬁltration 
of small-to-medium-sized lymphocytes around the bronchioles; B,  High-power magniﬁcation: Centrocyte-like cells with plasma diﬀerentia-
tion.  Dutcher bodies were observed.
[2].  In this case,  we chose single-agent rituximab 
therapy because the lesion was small and conﬁned to 
the trachea [8].  At the time this report was written,  
no progression of disease had been seen for 2 years 
without further treatment.  Estimates of ﬁve-year 
overall survival for such a condition in various studies 
have ranged from 55ｵ to 79ｵ [9-13].  Although the 
prognostic factors are not well deﬁned,  the overall 
prognosis is generally good compared with that of 
other forms of NHL.
　 BALT can be induced by smoking,  rheumatoid 
arthritis,  or systemic sclerosis; moreover,  BALT 
lymphoma is associated with chronic inﬂammation [7].  
However,  the present case had no history of collagen 
disease or chronic inﬂammation.  It is well known that 
asbestos can cause malignant mesothelioma and lung 
cancer,  but several reports have failed to ﬁnd an 
increased risk of NHL associated with asbestos expo-
sure [14-17].  The present case might have aﬀected 
by asbestos,  as revealed by the presence of pleural 
plaques.  In addition,  smoking is not a risk factor or 
is a weak risk factor for NHL [18,  19].  We cannot 
exclude the possibility of a simple coincidence of 
asbestos,  smoking,  and tracheal lymphoma in the 
present case.  However we could speculate that asbes-
tos and smoking might have resulted in multiplicative 
eﬀects promoting the development or progression of 
tracheal lymphoma.
　 NHL with asbestos exposure has been reported in 
rare cases,  such as one case of tonsilar lymphoma 
[20].  However,  no report was found in MEDLINE 
using the key words “trachea”,  “lymphoma”,  “malig-
nat” and “asbestos”,  which suggests that this case 
might probably be the ﬁrst of its kind to be reported.
　 Thus,  similar to this patient,  individuals exposed 
to asbestos might beneﬁt from not only receiving regu-
lar checkups by chest CT but also refraining from 
smoking in order to avoid malignancy.
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